Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 4

2(66.7%)

N/A

1(33.3%)

3Total

Phase 4(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT05590988Not ApplicableCompleted

Sensorimotor Arm Rehabilitation After Stroke

Role: collaborator

NCT06493006Recruiting

Promoting Sustainable and Active Mobility Among Employees and Students

Role: collaborator

NCT02035540Completed

European Clinical Study for the Application of Regenerative Heart Valves - ESPOIR

Role: collaborator

NCT01089231Phase 4Completed

Effects of Omega-3 Fatty Acids on the Human Gene Expression

Role: lead

NCT01214278Phase 4Completed

Bioavailability of Different n-3 Fatty Acid Formulations

Role: lead

All 5 trials loaded